Enzalutamide

Drug Class or Subclass

Hormonal agents

Androgen receptor inhibitor

Generic

Enzalutamide

Brand Name

Xtandi

Import ID

181

Displaying 1 - 4 of 4

	Interaction Color Code	Clinical Bottom Line	Clinical Effects	Drug 1 effect	Drug 2 dose	Drug 2 effect	Management
Doravirine Enzalutamide 348	Red: Avoid combination	Do not coadminister: Potential for reduced levels of doravirine	Potential decrease in antiretroviral efficacy				Contraindicated. Use alternative agents. If discontinuing enzalutamide, a minimum 4 week cessation period is recommended prior to initiating doravirine.
Cabotegravir Enzalutamide 334	Red: Avoid combination	Do not coadminister: Potential for reduced levels of CAB	Potential decrease in antiretroviral efficacy	Not studied		Not studied	Contraindicated. Use alternative agents.
Bictegravir Enzalutamide 72	Red: Avoid combination	Do not coadminister: Potential for reduced levels of BIC	Potential decrease in antiretroviral efficacy				Contraindicated. Use alternative agents.
Fostemsavir Enzalutamide 18	Red: Avoid combination	Do not coadminister: Potential for reduced levels of temsavir	Potential decrease in antiretroviral efficacy				Contraindicated. Use alternative agents.

Subscribe to Enzalutamide